Posted in | News | Nanomedicine | Nanobusiness

RainDance Technologies President and CEO to Discuss Impact of New Transformational Tools Shaping Life Sciences

Christopher McNary, RainDance Technologies President and Chief Executive Officer, will discuss the impact of new transformational tools shaping life sciences research during a panel session at the 2009 BIO International Convention in Atlanta on May 20, 2009.

The session, Transformational Tools: How New Research Technologies Are Changing the Rules of the Game, will review how the accessibility and power of these new tools are empowering individual scientists to conduct research that was formerly infeasible, unaffordable, or threatening to the research status quo.

In his remarks, McNary will discuss how exciting new technologies are enabling researchers to rethink the way they design experiments and approach discovery, permitting the achievement of previously unattainable breakthrough science. He will cite that the capabilities of his company’s RainStormTM microdroplet-based technology platform can be applied across a wide range of biomedical research applications. For example, McNary will describe how a researcher can collect a heterogeneous group of cells of interest, such as a cancer sample, break it down into homogeneous collections of primary cells such as tumor and stem cells, capture and interrogate these as single cells, and perform scientific analyses. This capability will help make exciting strides in understanding the fundamental biology of complex disease.

In addition, McNary will explain how the RainStorm platform also is being applied in collaboration with sanofi-aventis to develop game-changing high-throughput screening methodologies for drug discovery. This work will accelerate the discovery process by enabling pharmaceutical companies to make better and faster decisions about what compounds should be pulled through their development pipelines. McNary will review how these new workflows minimize experimental unknowns, permit simple sample manipulation, and generate accurate measurements at levels unimaginable only a few years ago.

McNary and the other chief executives on the panel also will describe the radical innovations, new perspectives, and diverse disciplines underlying these new technologies, as well as challenges to development and commercialization.

To learn more, visit the RainDance Technologies Website at www.raindancetech.com, or call 781-861-6300.

For more information about the 2009 BIO International Convention, visit http://convention.bio.org/.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bio-Rad Laboratories India Pvt. Ltd.. (2019, February 14). RainDance Technologies President and CEO to Discuss Impact of New Transformational Tools Shaping Life Sciences. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=11318.

  • MLA

    Bio-Rad Laboratories India Pvt. Ltd.. "RainDance Technologies President and CEO to Discuss Impact of New Transformational Tools Shaping Life Sciences". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=11318>.

  • Chicago

    Bio-Rad Laboratories India Pvt. Ltd.. "RainDance Technologies President and CEO to Discuss Impact of New Transformational Tools Shaping Life Sciences". AZoNano. https://www.azonano.com/news.aspx?newsID=11318. (accessed November 21, 2024).

  • Harvard

    Bio-Rad Laboratories India Pvt. Ltd.. 2019. RainDance Technologies President and CEO to Discuss Impact of New Transformational Tools Shaping Life Sciences. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=11318.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.